Lettmann Jason

Average Profitability
90.48%
Insider Buys Quantity
2
Insider Buys Sum
$15.25M
Insider Sells Quantity
4
Insider Sells Sum
$13.6M

Insider Activity of Lettmann Jason

According to the SEC Form 4 filings, Lettmann Jason, being in a position of

  1. CHIEF EXECUTIVE OFFICER at ALX Oncology Holdings Inc.,
    оver the last 12 months, has bought 4400 shares for $49,771, and sold 0 shares,
    over all time since 2020-07-21, has bought 804400 shares for $15.25M, and sold 471014 shares for $13.6M.

The largest purchase of all time was on 2020-07-21 and amounted to 800000 shares of ALX Oncology Holdings Inc. for $15.2M.

The largest sale of all time was on 2021-12-13 and amounted to 325377 shares of ALX Oncology Holdings Inc. for $8.9M.

Biography of Lettmann Jason

No biography is available at this moment.

2024-03-14PurchaseALX Oncology Holdings Inc.
ALXO
CHIEF EXECUTIVE OFFICER
4,400
0.0085%
$11.31$49,771-40.77%
2021-12-13SaleALX Oncology Holdings Inc.
ALXO
325,377
0.9374%
$27.36$8.9M-46.92%
2021-12-10SaleALX Oncology Holdings Inc.
ALXO
26,274
0.0657%
$31.31$822,719-59.43%
2021-12-09SaleALX Oncology Holdings Inc.
ALXO
76,905
0.2004%
$32.03$2.46M-58.62%
2021-12-08SaleALX Oncology Holdings Inc.
ALXO
42,458
0.1058%
$33.25$1.41M-61.83%
2020-07-21PurchaseALX Oncology Holdings Inc.
ALXO
800,000
1.6653%
$19.00$15.2M+90.48%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.